GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Avinger Inc (STU:VG20) » Definitions » Cash And Cash Equivalents

Avinger (STU:VG20) Cash And Cash Equivalents : €8.18 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Avinger Cash And Cash Equivalents?

Avinger's quarterly cash and cash equivalents increased from Dec. 2023 (€4.84 Mil) to Mar. 2024 (€6.60 Mil) and increased from Mar. 2024 (€6.60 Mil) to Jun. 2024 (€8.18 Mil).

Avinger's annual cash and cash equivalents declined from Dec. 2021 (€17.26 Mil) to Dec. 2022 (€13.79 Mil) and declined from Dec. 2022 (€13.79 Mil) to Dec. 2023 (€4.84 Mil).


Avinger Cash And Cash Equivalents Historical Data

The historical data trend for Avinger's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avinger Cash And Cash Equivalents Chart

Avinger Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.85 18.24 17.26 13.79 4.84

Avinger Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.58 8.18 4.84 6.60 8.18

Avinger Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Avinger  (STU:VG20) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Avinger Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Avinger's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Avinger Business Description

Traded in Other Exchanges
Address
400 Chesapeake Drive, Redwood City, CA, USA, 94063
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

Avinger Headlines

No Headlines